PRO/C5 cases were uniformly low in tumor-infiltrating CD3+ and CD8+ cells, suggesting poor engagement of the immune system against the tumor within this patient group; this may partially account for the shorter survival time previously described in these cases (17, 19). The gene discussed is CD8A; the disease is neoplasm.